Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

• Published in: Prostate cancer and prostatic diseases Vol. 28; no. 3; pp. 832 - 833
• Main Authors: Secco, Silvia, Olivero, Alberto, Longoni, Mattia, Dell’Oglio, Paolo, Tappero, Stefano, Dibilio, Edoardo, Saccucci, Tommaso, Siena, Giampaolo, Bocciardi, Aldo Massimo, Galfano, Antonio, Cindolo, Luca
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.09.2025; Nature Publishing Group
• Subjects: 692/308/409; 692/699/2768; Aged; Aged, 80 and over; Anesthesia; Anesthesia - methods; Anesthesia, Local - methods; Biomedical and Life Sciences; Biomedicine; Brief Communication; Cancer Research; Catheters; Data collection; Humans; Hyperplasia; Invasiveness; Male; Middle Aged; Minimally invasive surgery; Pain; Pain Measurement; Patients; Prostate cancer; Prostatic Hyperplasia - surgery; Reproductive Medicine; Surgical techniques; Systematic review; Transurethral Resection of Prostate - methods; Urogenital system; Visual observation; Israel
• ISSN: 1365-7852; 1476-5608; 1476-5608
• DOI: 10.1038/s41391-024-00892-2

Background/Objectives Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning. Subjects/Methods Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS). Results No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA. Conclusions SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.